ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RONALD HERRINGTON M.D.

Internal Medicine

17,828

$866K

474
316 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

ELIAS ISSA MD

Internal Medicine

17,680

$1.15M

571
440 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

RICHARD MCCULLOUGH MD

Internal Medicine

17,667

$1.13M

645
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

HEATH HAMPTON MD

Internal Medicine

17,451

$950K

600
513 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

DAVID DUVALL MD

Internal Medicine

17,449

$842K

529
478 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

JAMES HESTER M.D.

Internal Medicine

17,353

$650K

515
434 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

ERIC JENSEN M.D.

Internal Medicine

17,349

$956K

638
564 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

KENNETH FIGUEROA MD

Internal Medicine

17,332

$697K

497
456 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

ANDREW MCDONALD M.D.

Internal Medicine

17,227

$772K

732
616 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

RAUL GONZALEZ MD

Internal Medicine

17,168

$772K

599
510 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

JOHN HARSCH M.D.

Internal Medicine

17,133

$879K

1300
1111 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

FRANK COLE MD

Internal Medicine

16,974

$1.08M

884
806 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

JAMES FALCONER

Internal Medicine

16,878

$800K

598
478 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

SATYANARAYANA CHETI M.D.

Internal Medicine

16,866

$823K

420
300 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

SYDNEY HENDRIX M.D.

Internal Medicine

16,839

$748K

521
472 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

BRADLEY PIERCE M.D.

Internal Medicine

16,828

$761K

680
589 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

JAMES BARBER M. D.

Internal Medicine

16,801

$802K

603
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

JAMES PARKS MD

Internal Medicine

16,739

$786K

236
209 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

DAVID GOSE MD

Internal Medicine

16,734

$1.04M

821
664 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $56

RUSSELL MINOR M.D.

Internal Medicine

16,712

$913K

414
324 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

FRANCIS KUNDI M.D.

Internal Medicine

16,635

$971K

322
183 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

ZIA KHAN MD

Internal Medicine

16,629

$796K

487
428 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

PAUL BRADLEY MD

Internal Medicine

16,618

$1.11M

725
603 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $56

SANDEEP DSOUZA MD

Internal Medicine

16,600

$911K

506
353 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

ROBERT PRICE MD

Internal Medicine

16,584

$987K

654
421 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank